| Open Document File Size: 748,16 KBShare Result on Facebook
City Reference / / Company Alcon / Durezol Corticosteroid Alcon Research Ltd. / Double-Masked / / Country United States / / Event FDA Phase / M&A / Product Issues / Product Recall / / Facility Laboratory Findings / / IndustryTerm ophthalmic solution / pediatric study protocol / bromfenac ophthalmic solution / parallel / tromethamine ophthalmic solution / sodium ophthalmic solution / / MedicalCondition photophobia / keratitis / corticosteroid-responsive inflammation / post-operative inflammation / superficial punctate keratitis / responsive inflammatory conditions / herpes zoster keratitis / acne rosacea / sympathetic ophthalmia / ocular itching / herpes / age undergoing cataract / posterior subcapsular cataract / seasonal allergic conjunctivitis / allergic conjunctivitis / pain / post-operative inflammation I / endogenous anterior uveitis / steroid-responsive inflammation / infective conjunctivitides / iritis / burns / temporal arteritis / Currently Available Post-Operative Inflammation / ocular inflammatory conditions / inflammation / corneal injury / cataract / uveitis / secondary ocular infection / / MedicalTreatment surgery / cataract surgery / radiation / / Organization Division of Scientific Investigations / PDUFA Goal Date Division / Advisory Committee / / Person Review Lucious Lim / Lucious Lim / / Position investigator / Currently Available Post-Operative / Major / / Product FML / Overdose / Pred Forte / Acular / Acular LS / Nevanac / Voltaren / Prednisolone acetate / Ophthalmic Suspension / diclofenac sodium / Triesence / dexamethasone sodium phosphate / ketorolac tromethamine / Kenalog / Maxidex / triamcinolone acetonide / Lotemax / Flarex / FML Forte / Xibrom / Vexol / C-10-004 / US / ST-601-007 / SE5-011 / / PublishedMedium the DSI review / / Technology radiation / pediatric study protocol / /
SocialTag |
N22-212S011 Difluprednate Clinical BPCA